BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
This specialized formulation features transferrin-modified triptolide liposomes engineered as an affinity-coupled target modeling matrix. The vesicle architecture utilizes a stable phospholipid bilayer shell whose exterior boundary is covalently functionalized with transferrin glycoprotein ligands linked via polymer-lipid anchors, while the internal hydrocarbon domain encapsulates the hydrophobic diterpenoid trioxide triptolide. This surface modification alters the surface charge topography, membrane elasticity, and introduces a dense macromolecular shield that prevents physical vesicle aggregation and isolates the active core from premature cargo crystallization. The resulting vesicles exhibit high colloidal stability and a highly uniform spherical morphology.
Source
Custom synthesis
Functional Group
Transferrin; Triptolide
Form
Solid or powder
Purity
≥95%
Impurities
No visible impurities to the naked eye.
Identity
HPLC/MS/NMR
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.